Some causes of poor adherence to long-term statin therapy and their solution
| Autor: | Ondřej Kyselák, Vladimír Soška |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Renal function 030204 cardiovascular system & hematology Medication Adherence Poor adherence 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Risk Factors Internal Medicine Medicine Humans cardiovascular diseases Adverse effect Intensive care medicine Kidney Cholesterol business.industry nutritional and metabolic diseases Statin treatment medicine.anatomical_structure chemistry Cardiovascular Diseases lipids (amino acids peptides and proteins) Statin therapy Liver function Hydroxymethylglutaryl-CoA Reductase Inhibitors Cardiology and Cardiovascular Medicine business 030217 neurology & neurosurgery |
| Zdroj: | Vnitrni lekarstvi. 64(10) |
| ISSN: | 0042-773X |
| Popis: | Statins are among the most important drugs in preventive cardiology because they greatly improve the prognosis of risk patients in both primary and secondary prevention of atherosclerotic cardiovascular disease. Adherence to long-term statin therapy is poor and decreases with the duration of statin use. A number of fake news about adverse effects of statins disseminated on the internet, such as damage of the brain, liver or kidney, contribute to worsening adherence. Statins therapy is sometimes unnecessary discontinued before planned surgery. The worse adherence to statin therapy may be also due to the fact that the patient does not know the connection between cholesterol lowering and improving his cardiovascular prognosis. Key words: adherence - brain - cholesterol - liver function - renal function - statins - surgery. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|